Risk Model Predicts Response and Survival in Metastatic Cancer Patients
Risk model based on routine blood work predicts treatment response and survival of metastatic cancer patients treated with immune checkpoint…
Risk model based on routine blood work predicts treatment response and survival of metastatic cancer patients treated with immune checkpoint…
A study led by the NUS Yong Loo Lin School of Medicine discovered that certain breast tumour cells sacrifice their…
A new deep learning challenge has been launched by the UEF Cancer AI research team at the University of Eastern…
Plans for a new cancer support centre in Cardiff have been given a £1 million boost, thanks to the generosity…
Dr Saladin Sawan, Consultant Surgeon in Gynaecological Oncology and one of our faculty trainers, recently returned from a surgical mission…
Breast cancer survivors: new training to treat 'chemo-brain': A form of computerised attention and memory training can improve impaired attention…
Leukaemia UK has today announced that it will channel £600,000 into four new research projects, each aimed at finding kinder,…
A major stone sculpture honouring all serving and veteran members of the British Armed Forces with the asbestos-related cancer, mesothelioma,…
Breakthrough in the fight against resistance in metastatic breast cancer research: A team of researchers at the Medical University of…
Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled…
This website uses cookies.